Association Between Polymorphism Within Interleukin Related Genes and Graves' Disease: a Meta-analysis of 22 Case-control Studies

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Dec 13

PMID 29228744

Citations 5

Authors

Yaqin Tu

Guorun Fan

Tianshu Zeng

Xiong Cai

Wen Kong

Affiliations

Soon will be listed here.

Abstract

Graves' disease (GD) is a common autoimmune disorder with a genetic predisposition. There is strong evidence to suggest that both Th1 and Th2 circulating cytokines are involved in the development of GD. In this study, we conducted a meta-analysis to assess the impact of seven variations of five -related genes on the susceptibility to GD. A total of 22 case-control studies involving 5338 GD patients and 6446 healthy controls were included. The results showed that only one SNP rs1800795 in -6 was significantly associated with GD in homozygous model (CC vs. GG: OR = 2.714, 95% CI = 1.047-7.039, = 0.04), heterozygous model (CG vs. GG: OR = 1.295, 95% CI = 1.013-1.655, = 0.039), dominant model (CC+CG vs. GG: OR = 1.418, 95% CI = 1.122-1.793, = 0.003) and additive model (C vs. G: OR = 1.432, 95% CI = 1.087-1.886, p = 0.011).To explain the heterogeneity, we performed the subgroup analysis by ethnicity. The ethnicity stratification revealed that the association between rs1800795 and GD tended to be much stronger for Asian than European population in homozygous, dominant, recessive, and additive models. The remaining 6 SNPs in 4 genes did not show any significant association with GD in any genetic models. Together, our data support that rs1800795 within the -6 gene confers genetic susceptibility for GD. Future large-scale studies are required to validate the associations between -6 and others -related genes and GD.

Citing Articles

IL-17 and IL-38 gene polymorphisms in thyroid-associated ophthalmopathy.

Mussakulova A, Balmukhanova A, Aubakirova A, Khamdiyeva O, Zhunussova G, Balmukhanova A Int Ophthalmol. 2024; 44(1):379.

PMID: 39292290 DOI: 10.1007/s10792-024-03317-0.

IL-3: key orchestrator of inflammation.

Podolska M, Grutzmann R, Pilarsky C, Benard A Front Immunol. 2024; 15:1411047.

PMID: 38938573 PMC: 11208316. DOI: 10.3389/fimmu.2024.1411047.

IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker.

Wang Y, Mao X, Liu Y, Yang Y, Jin H, Li L Front Immunol. 2022; 13:824110.

PMID: 35140724 PMC: 8818855. DOI: 10.3389/fimmu.2022.824110.

A data-driven approach for the discovery of biomarkers associated with thyroid eye disease.

Zou H, Xu W, Wang Y, Wang Z BMC Ophthalmol. 2021; 21(1):166.

PMID: 33832456 PMC: 8034124. DOI: 10.1186/s12886-021-01903-9.

Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.

Tabatabaei-Panah P, Moravvej H, Sadaf Z, Babaei H, Geranmayeh M, Hajmanouchehri S Front Immunol. 2019; 10:636.

PMID: 31001258 PMC: 6455081. DOI: 10.3389/fimmu.2019.00636.

References

Shiau M, Huang C, Yang T, Hwang Y, Tsai K, Chi C . Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease. Clin Biochem. 2007; 40(3-4):213-7. DOI: 10.1016/j.clinbiochem.2006.11.009. View

Trinchieri G . Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995; 13:251-76. DOI: 10.1146/annurev.iy.13.040195.001343. View

Brix T, Kyvik K, Hegedus L . A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab. 2000; 85(2):536-9. DOI: 10.1210/jcem.85.2.6385. View

Yang Y, Lingling S, Ying J, Yushu L, Zhongyan S, Wei H . Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J Hum Genet. 2005; 50(11):574-582. DOI: 10.1007/s10038-005-0297-x. View

Brix T, Kyvik K, Christensen K, Hegedus L . Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001; 86(2):930-4. DOI: 10.1210/jcem.86.2.7242. View

Cigrovski Berkovic M, Jokic M, Marout J, Radosevic S, Zjacic-Rotkvic V, Kapitanovic S . IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Exp Mol Pathol. 2007; 83(3):474-9. DOI: 10.1016/j.yexmp.2007.08.018. View

Zhu W, Liu N, Zhao Y, Jia H, Cui B, Ning G . Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease. J Endocrinol Invest. 2010; 33(10):751-5. DOI: 10.1007/BF03346682. View

Trinchieri G . Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003; 3(2):133-46. DOI: 10.1038/nri1001. View

Lee Y, Huang C, Ting W, Lee H, Guo W, Chen W . Association of an IL-4 gene haplotype with Graves disease in children: experimental study and meta-analysis. Hum Immunol. 2011; 72(3):256-61. DOI: 10.1016/j.humimm.2010.12.014. View

10.

Barbieri M, Rizzo M, Papa M, Acampora R, De Angelis L, Olivieri F . Role of interaction between variants in the PPARG and interleukin-6 genes on obesity related metabolic risk factors. Exp Gerontol. 2005; 40(7):599-604. DOI: 10.1016/j.exger.2005.05.004. View

11.

Khalilzadeh O, Anvari M, Momen-Heravi F, Esteghamati A, Rashidi A, Mahmoudi M . Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease. Clin Exp Med. 2009; 10(2):123-8. DOI: 10.1007/s10238-009-0078-5. View

12.

Anvari M, Khalilzadeh O, Esteghamati A, Momen-Heravi F, Mahmoudi M, Abdar Esfahani S . Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ. Endocrine. 2010; 37(2):344-8. DOI: 10.1007/s12020-010-9311-y. View

13.

Tait K, Nithiyananthan R, Heward J, Barnett A, Franklyn J, Gough S . Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK. Autoimmunity. 2004; 37(3):189-94. DOI: 10.1080/08916930410001666631. View

14.

Tian G, Li J, Wang D, Zhou D . Targeting IL-10 in auto-immune diseases. Cell Biochem Biophys. 2014; 70(1):37-49. DOI: 10.1007/s12013-014-9903-x. View

15.

Nanba T, Watanabe M, Akamizu T, Iwatani Y . The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem. 2008; 54(3):621-3. DOI: 10.1373/clinchem.2007.099739. View

16.

Hunt P, Marshall S, Weetman A, Bell J, Wass J, Welsh K . Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab. 2000; 85(5):1984-8. DOI: 10.1210/jcem.85.5.6588. View

17.

Akamizu T, Hiratani H, Ikegami S, Rich S, Bowden D . Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J Hum Genet. 2003; 48(5):236-242. DOI: 10.1007/s10038-003-0017-3. View

18.

McLeod D, Cooper D . The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012; 42(2):252-65. DOI: 10.1007/s12020-012-9703-2. View

19.

Inoue N, Watanabe M, Morita M, Tatusmi K, Hidaka Y, Akamizu T . Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 2011; 163(3):318-23. PMC: 3048614. DOI: 10.1111/j.1365-2249.2010.04306.x. View

20.

Heward J, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn J, Gough S . No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab. 2001; 86(8):3861-3. DOI: 10.1210/jcem.86.8.7744. View